Association of plasma adipokines with chronic obstructive pulmonary disease severity and progression.

Annals of the American Thoracic Society, 2015; 12 (7) doi:10.1513/AnnalsATS.201501-005OC

Authors: Oh Yeon-Mok, Jeong Byeong-Ho, Woo Sook-Young, Kim Su-Young, Kim Hojoong et al.(10)

Affiliation: University of Ulsan College of Medicine, Seoul, South Korea; Sungkyunkwan University School of Medicine, Seoul, South Korea; Samsung Biomedical Research Institute, Seoul, South Korea; Sungkyunkwan University School of Medicine, Seoul, South Korea; Sungkyunkwan University School of Medicine, Seoul, South Korea (show more (10))

Sample size: 196

Abstract: RATIONALE: Two adipokines, leptin and adiponectin, regulate metabolic and inflammatory systems reciprocally. The role of adiponectin in chronic obstructive pulmonary disease (COPD) has been studied. However, there are few data evaluating the relationship of plasma leptin with COPD severity or progression.
OBJECTIVES: The objective of this study was to evaluate the relationship of leptin, adiponectin, and the leptin/adiponectin ratio with COPD severity and progression according to COPD phenotypes.
METHODS: Plasma leptin and adiponectin levels were measured in 196 subjects with COPD selected from the Korean Obstructive Lung Disease cohort. Using a linear regression model and mixed linear regression, we determined the relationship of plasma leptin and adiponectin levels and the leptin/adiponectin ratio to COPD severity and progression over 3 years.
MEASUREMENTS AND MAIN RESULTS: The concentration of adiponectin in plasma positively correlated with percent emphysema on initial computed tomography (CT) (adjusted P = 0.022), whereas plasma leptin concentrations and the leptin/adiponectin ratio exhibited a significant inverse correlation with initial FEV1 (adjusted P = 0.013 for leptin and adjusted P = 0.041 for leptin/adiponectin ratio). Increased plasma leptin and leptin/adiponectin ratio were significantly associated with change in percent emphysema over 3 years (adjusted P = 0.037 for leptin and adjusted P = 0.029 for leptin/adiponectin ratio), whereas none of the adipokines demonstrated an association with FEV1 decline over the 3-year period.
CONCLUSIONS: Plasma adiponectin and leptin vary according to COPD phenotypes. Plasma leptin and the leptin/adiponectin ratio, but not adiponectin, were significantly associated with changes in CT-assessed emphysema, suggesting a potential role as a biomarker in emphysema progression in patients with COPD.

Related patents


Map of newest papers for: plasma adipokines

The top research papers for the subject are placed on the map. Studies form clusters based on semantic relation.

Size of the point represents relevance of the paper.

You can pan and zoom the graph using mouse and mouse wheel.

Right click on the paper to:

  • a) open the paper
  • b) to open first author’s resume page.

Left click on keyword to add it to search.

Sign up to create your own map!